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Abstract: To repair a DNA double-strand break by homologous recombination, 5’-terminated DNA
strands must first be resected to reveal 3’-overhangs. This process is initiated by a short-range resection
catalyzed by MRE11-RAD50-NBS1 (MRN) stimulated by CtIP, which is followed by a long-range step
involving EXO1 or DNA2 nuclease. DNA2 is a bifunctional enzyme that contains both single-stranded
DNA (ssDNA)-specific nuclease and motor activities. Upon DNA unwinding by Bloom (BLM) or Werner
(WRN) helicase, RPA directs the DNA2 nuclease to degrade the 5’-strand. RPA bound to ssDNA also
represents a barrier, explaining the need for the motor activity of DNA2 to displace RPA prior to resection.
Using ensemble and single-molecule biochemistry, we show that CtIP also dramatically stimulates the
adenosine 5’-triphosphate (ATP) hydrolysis-driven motor activity of DNA2 involved in the long-range
resection step. This activation in turn strongly promotes the degradation of RPA-coated ssDNA by
DNA2. Accordingly, the stimulatory effect of CtIP is only observed with wild-type DNA2, but not the
helicase-deficient variant. Similarly to the function of CtIP to promote MRN, also the DNA2 stimulatory
effect is facilitated by CtIP phosphorylation. The domain of CtIP required to promote DNA2 is located
in the central region lacking in lower eukaryotes and is fully separable from domains involved in the
stimulation of MRN. These results establish how CtIP couples both MRE11-dependent short-range and
DNA2-dependent long-range resection and define the involvement of the motor activity of DNA2 in this
process. Our data might help explain the less severe resection defects of MRE11 nuclease-deficient cells
compared to those lacking CtIP.
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Abstract 29 
To repair a DNA double-strand break by homologous recombination, 5'-terminated DNA 30 
strands must first be resected to reveal 3'-overhangs. In human cells, this process is initiated 31 
by a short-range resection catalyzed by MRE11-RAD50-NBS1 (MRN) stimulated by CtIP, 32 
which is followed by a long-range step involving EXO1 or DNA2 nuclease. DNA2 is a bi-func-33 
tional enzyme that contains both ssDNA specific nuclease and motor activities. 34 
Upon DNA unwinding by BLM/WRN, RPA directs the DNA2 nuclease to degrade the 5'-35 
strand. RPA bound to ssDNA also represents a barrier, explaining the need for the motor ac-36 
tivity of DNA2 to displace RPA prior to resection. Using ensemble and single molecule bio-37 
chemistry, we show that CtIP also dramatically stimulates the ATP hydrolysis driven motor 38 
activity of DNA2 involved in the long-range resection step. This activation in turn strongly 39 
promotes the degradation of RPA-coated ssDNA by DNA2. Accordingly, the stimulatory ef-40 
fect of CtIP is only observed with wild type DNA2, but not the helicase-deficient variant. 41 
Similarly to the function of CtIP to promote MRN, also the DNA2 stimulatory effect is facili-42 
tated by CtIP phosphorylation. The domain of CtIP required to promote DNA2 is located in 43 
the central region lacking in lower eukaryotes, and is fully separable from domains involved 44 
in the stimulation of MRN. These results establish how CtIP couples both MRE11-dependent 45 
short and DNA2-dependent long-range resection, and define the involvement of the motor 46 
activity of DNA2 in this process. Our data explain the less severe resection defects of MRE11 47 
nuclease-deficient cells compared to those lacking CtIP. 48 
 49 
Significance Statement 50 
Homologous recombination is initiated by a two-step nucleolytic processing of DNA breaks 51 
to generate overhangs required for the downstream steps in the repair pathway. The first 52 
resection step is slow but versatile, while the second step is fast but sensitive to protein ad-53 
ducts or secondary DNA structures. Our results support a model where CtIP is a co-factor 54 
that stimulates both the short-range and long-range nucleolytic processing. Specifically, we 55 
define here the interplay of CtIP and the DNA2 nuclease-helicase that functions is long-56 
range resection. The control of both resection steps by CtIP likely allows more precise regu-57 
lation of DNA end processing and initiation of homologous recombination. 58 
 59 




DNA double-strand breaks (DSBs) in eukaryotes are repaired by end-joining or homology-63 
directed pathways (1). End-joining, including both non-homologous and microhomology-64 
mediated sub-pathways require only minimal processing of the DNA ends and may involve 65 
limited microhomology at the break sites to facilitate ligation. Homologous recombination 66 
instead utilizes genetic information stored in an intact DNA copy, usually the sister chroma-67 
tid in vegetative cells, to serve as a template for mostly accurate repair. There are several 68 
distinct sub-pathways of homology-directed repair, including single-strand annealing that 69 
leads to large deletions, synthesis-dependent strand annealing, break induced replication 70 
and canonical DNA double-strand break repair (1). While these pathways differ in mecha-71 
nisms and resulting genetic outcomes, their common denominator is the first step, termed 72 
DNA end resection. All recombination pathways are initiated by nucleolytic degradation of 73 
the 5'-terminated DNA strand at DSB sites, leading to extended stretches of 3'-terminated 74 
ssDNA, which are required for the downstream steps in all the respective pathways (2, 3). 75 
Extensive DNA end resection commits the DSB repair to recombination, as resected ends 76 
are no longer ligatable by end-joining pathways. Cyclin-dependent kinases (CDK) regulate 77 
DNA end resection to be allowed only in the S and G2 phases of the cell cycle, when sister 78 
chromatids are available (4-9). 79 
Intensive research established that DNA end resection generally consists of two subse-80 
quent steps. In human cells, resection is initiated by the MRE11-RAD50-NBS1 (MRN) com-81 
plex, which functions in conjunction with CtIP (10, 11). CtIP activates the MRE11 endonucle-82 
ase within the MRN complex (12, 13). The activated MRN complex then preferentially 83 
cleaves the 5'-terminated DNA strand past protein blocks. Therefore, this step is particularly 84 
important to process DNA ends with non-canonical structures, including bound proteins like 85 
Ku and topoisomerases, as well as secondary DNA structures (14-18). CtIP is phosphorylated 86 
by multiple kinases including CDK, ATM and ATR. In particular, the T847 CDK site of CtIP 87 
must be phosphorylated to promote MRN, which represents a mechanism that allows cell-88 
cycle dependent control of DNA end resection (5, 13, 19-21). 89 
Downstream of this initial short-range processing, either of two partially redundant nu-90 
cleases catalyze long-range 5'-end resection that can extend up to several kilobases in 91 
length (22-27). The Exonuclease 1 (EXO1) degrades 5'-terminated DNA strand within dsDNA. 92 
 4 
The nuclease-helicase DNA2 instead degrades ssDNA, and thus requires a helicase partner 93 
to unwind dsDNA, which can be either the Bloom (BLM) or Werner (WRN) RecQ family hel-94 
icase  (28-30). Both BLM/WRN and DNA2 function in conjunction with the single-strand DNA 95 
binding protein RPA, which promotes DNA unwinding by BLM/WRN and directs DNA2 to de-96 
grade the 5'-terminated ssDNA strand (31-33). The structure of murine DNA2 revealed that 97 
the polypeptide possesses a central cavity through which ssDNA needs to thread before it 98 
can be cleaved (33). As the size of the cavity only accommodates ssDNA, bound proteins, in-99 
cluding RPA, need to be displaced prior to degradation (33, 34). The nuclease activity of 100 
DNA2 is essential for its function in resection and cell viability (24). However, DNA2 also has 101 
a conserved helicase domain (34, 35). Although the helicase-deficient DNA2 mutants are 102 
equally lethal, the function of this activity has remained enigmatic (36). The helicase of 103 
DNA2 in resection cannot replace the helicase of BLM/WRN (26). The unwinding capacity of 104 
wild type DNA2 is very weak, and processive DNA unwinding is only observed upon inactiva-105 
tion of the nuclease activity (29, 35, 37). The motor activity of DNA2 was thus proposed to 106 
promote resection not as a helicase to unwind dsDNA, but rather as a ssDNA translocase to 107 
act downstream of the RecQ family helicase partner (38, 39). In this model, BLM and WRN 108 
function as the lead helicases that unwind dsDNA. This provides long stretches of RPA 109 
coated 5'-terminated ssDNA to DNA2, which uses its motor activity to translocate along the 110 
ssDNA to displace RPA and feed the ssDNA strand to the nuclease domain (38).  111 
The phenotypes of human CtIP-depleted cells or corresponding S. cerevisiae sae2D mu-112 
tants were reported to be more severe than those of MRE11/Mre11 nuclease point mu-113 
tants, indicating that CtIP/Sae2 have additional functions that go beyond stimulating the 114 
MRE11 nuclease. To this point, both Sae2 and CtIP were described to possess an intrinsic 115 
nuclease activity with functions in DNA end resection and beyond, which could explain the 116 
phenotypic differences (40-42). However, the Sae2/CtIP nuclease function remains contro-117 
versial (12, 18, 43). Sae2/CtIP may also have a structural role in DNA break repair to bridge 118 
DNA (18, 44). In yeast, sae2D mutants were found to hyperactivate checkpoint signaling. 119 
Checkpoint-defective sae2D mutants exhibited identical DNA damage sensitivity and resec-120 
tion defects as mre11 nuclease-dead mutants, showing that checkpoint hyperactivation ac-121 
counted for the differential phenotypes of the respective mutants (45-47). In higher eukary-122 
otes, however, the situation is more complex. While some studies reported similar sensitivi-123 
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ties of MRE11 nuclease-deficient (resulting from point mutations or small molecule inhibi-124 
tors) and CtIP-deficient cells (11), other reports point out more severe defects upon CtIP de-125 
pletion. Specifically, in Xenopus egg extracts, complete inhibition of resection was observed 126 
upon depletion of EXO1 and CtIP, inferring that DNA2 requires CtIP to perform long-range 127 
resection (48). Likewise, epistatic relationships between CtIP and DNA2 were found in 128 
chicken DT40 cells (49). Disruption of the MRE11 nuclease active site did not dramatically 129 
reduce resection, in contrast to CtIP-deficient cells, which exhibited a severe defect (50). 130 
Similarly, inactivation of the MRE11 nuclease was less severe than disruption of CtIP in hu-131 
man TK6 cells (50). Finally, single molecule analysis of DNA resection tracks showed that 132 
CtIP contributes to fast resection at long distances from the DNA end (51), which disagrees 133 
with the expected range of the MRN-dependent short-range resection. Together, these re-134 
ports suggest that CtIP may promote long-range DNA end resection by an unknown mecha-135 
nism. In accord, CtIP was shown to physically interact with and promote DNA unwinding by 136 
the BLM helicase, as well as to modestly stimulate DNA degradation by the DNA2 nuclease 137 
(52). Using ensemble and single molecule biochemistry, we show here that phosphorylated 138 
CtIP dramatically stimulates the motor activity of DNA2. This accelerates degradation of 139 
RPA-coated ssDNA by DNA2, showing the need for the motor activity of DNA2 to facilitate 140 
resection. Our results show that CtIP is thus a co-factor not only of MRE11, but also of 141 
DNA2, and demonstrate that the domains of CtIP required for the stimulation of MRN and 142 
DNA2 are physically separate. Our data support a model where CtIP first activates the 143 
MRE11 nuclease, and then helps couple short-range resection with the downstream long-144 
range step by promoting DNA2. These results explain the dramatic DNA end resection de-145 





CtIP promotes DNA2-dependent long-range DNA end resection pathway 150 
CtIP functions as a co-factor of the MRN endonuclease acting in the initial short-range DNA 151 
end resection pathway (13)(SI Appendix, Fig. S1A). Multiple studies however indicated that 152 
deficiency of CtIP has a stronger impact on resection than mutations or inhibition of the 153 
MRE11 nuclease (48-50) (see also SI Appendix, Fig. S1B), suggesting that CtIP has additional 154 
functions in resection beyond promoting MRE11. To study the effect of CtIP on long-range 155 
DNA end resection pathways in a defined system, we expressed and purified phosphory-156 
lated human CtIP (pCtIP) in the presence of phosphatase inhibitors, DNA2, BLM, WRN and 157 
EXO1 (SI Appendix, Fig. S1C−S1G) in Sf9 cells. Recombinant pCtIP did not promote DNA deg-158 
radation by EXO1 (SI Appendix, Fig. S1H), but stimulated DNA end resection by BLM-DNA2-159 
RPA (SI Appendix, Fig. S1I−S1K), as well as by WRN-DNA2-RPA (Fig. 1A, compare lanes 6 and 160 
9). To understand the stimulation of resection by pCtIP in detail, we next investigated its ef-161 
fect on the activities of BLM/WRN and DNA2 individually. pCtIP stimulated DNA unwinding 162 
by BLM ~2-fold (SI Appendix, Fig. S1L), as well as to a similar extent the nuclease of DNA2 on 163 
oligonucleotide-based substrates (Fig. 1B−1C), as noted previously (52). In contrast, pCtIP 164 
did not significantly promote DNA unwinding by WRN (SI Appendix, Fig. S1M). The strongest 165 
stimulatory effect by pCtIP was observed when we assayed DNA unwinding by nuclease-166 
dead DNA2 D277A (Fig. 1D−1E). With pCtIP, 0.25 nM DNA2 D277A unwound more than 50% 167 
of the Y-structured DNA substrate, which was more than that unwound by 30 nM DNA2 168 
D277A without pCtIP, corresponding to >10-fold stimulation (Fig. 1D−1E). Recombinant 169 
pCtIP thus predominantly promotes the motor activity of DNA2. 170 
  171 
CtIP dramatically promotes long-range ssDNA degradation by DNA2  172 
To define the function of pCtIP in regulating DNA2 in a simple system, we next used an assay 173 
that monitors 5'→3' degradation of 3' end-labeled fragments of ssDNA by wild type DNA2. 174 
The use of ssDNA bypasses the requirement for BLM or WRN helicase. Without pCtIP, the 175 
degradation of ssDNA by DNA2 was slow (Fig. 2A, lanes 3-7), and was strikingly ~10-fold 176 
stimulated when pCtIP was included in the reactions (Fig 2A, lanes 9-13, Fig. 2B). While 177 
pCtIP appears to accelerate ssDNA degradation by DNA2, it did not change the 5'→3' polar-178 
ity of DNA degradation in the presence of RPA (SI Appendix, Fig. S2A−S2B). Likewise, pCtIP 179 
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did not allow DNA2 to cleave ssDNA endonucleolytically when DNA ends were blocked (SI 180 
Appendix, Fig. S2A−S2B). Low nanomolar concentrations of both pCtIP and DNA2 were re-181 
quired for maximal DNA degradation under our conditions (Fig. 2C−2F). We note that 1 nM 182 
DNA2 in the presence of pCtIP was more efficient in DNA degradation than 20 nM DNA2 183 
without pCtIP (compare Fig. 2E, lane 7 with Fig. 2A, lane 7), highlighting the dramatic stimu-184 
lation of the ssDNA degradative capacity of DNA2 by pCtIP. 185 
 186 
The motor activity of DNA2 mediates the accelerated ssDNA degradation with pCtIP 187 
To define the mechanism of the stimulatory effect of pCtIP on the DNA2 nuclease, we set 188 
out to investigate the role of the motor activity of DNA2 in this process. Strikingly, pCtIP 189 
strongly stimulated ssDNA degradation by DNA2 only in the presence of ATP (Fig. 3A−3B). 190 
Importantly, pCtIP had no activity on its own with or without ATP (Fig. 3A, lanes 6 and 7). 191 
Furthermore, pCtIP did not notably promote ssDNA degradation by the helicase-deficient 192 
with disrupted ATPase site DNA2 K654R variant (Fig. 3C−3D). We also note that pCtIP 193 
strongly promoted the ATPase activity of DNA2 (Fig. 3E−3F), while no ATP hydrolysis was ob-194 
served when using the DNA2 K654R variant, as expected (SI Appendix, Fig. S3A). Assuming 195 
our DNA2 preparation is 100% active, the experiments indicate an apparent kcat for DNA2 196 
without pCtIP of ~10 sec-1, which was ~5-fold stimulated when pCtIP was included in the re-197 
action. These experiments together demonstrate the importance of ATPase-driven trans-198 
locase activity of DNA2 in extended ssDNA degradation. 199 
No DNA degradation was observed when using the nuclease-deficient DNA2 D277A (Fig. 200 
3C−3D) even in the presence of pCtIP, further demonstrating that the observed nuclease ac-201 
tivity was intrinsic to DNA2 and not a result of non-specific contamination in our assays. Hu-202 
man pCtIP did not promote ssDNA degradation by yeast Dna2 and vice versa, yeast pSae2 203 
did not promote the nuclease of human DNA2 (Fig. 3G, SI Appendix, Fig. S3B−S3C), implicat-204 
ing direct species-specific interactions between the human polypeptides. Furthermore, 205 
pSae2 did not notably stimulate yeast Dna2, showing that the interplay described here is 206 
specific to higher eukaryotes. The species-specific interplay of cognate human pCtIP and 207 
DNA2 suggested the proteins might directly physically interact. Indeed, FLAG-tagged DNA2 208 
could readily pull down pCtIP, demonstrating a direct interaction (Fig. 3H). Together, these 209 
results establish that by forming a complex, pCtIP stimulates the motor activity of DNA2, 210 
which in turn accelerates its ssDNA degradative capacity.  211 
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 212 
Single-molecule experiments reveal the acceleration of DNA unwinding rate of DNA2 by 213 
pCtIP 214 
To further mechanistically define the stimulation of DNA2 motor by pCtIP, we employed 215 
magnetic tweezers, which monitor the position of a magnetic bead linked by a single DNA 216 
molecule to a fixed surface. As ssDNA is extended compared to dsDNA, DNA unwinding can 217 
be inferred from the relative position of the bead and DNA extension curve. We could not 218 
directly monitor the DNA2 nuclease in our setup, because DNA must be attached on both 219 
ends. Instead, we analyzed the effect of pCtIP on DNA unwinding by the nuclease-dead 220 
DNA2 D277A (Fig. 4A). The mean velocity of DNA2 D277A in the absence of pCtIP was 13 ± 1 221 
bp/s (SEM), which was increased ~7-fold in the presence of pCtIP to 86 ± 4 bp/s (SEM)(Fig. 222 
4B−C and SI Appendix, Fig. S4A). In contrast, pCtIP had no effect on the processivity of DNA2 223 
D277A (SI Appendix, Fig. S4B). While the motor activity of human DNA2 alone is slower than 224 
that of the yeast orthologue (29, 37), we note that in the presence of pCtIP, the unwinding 225 
activity of human DNA2 is faster than that by yeast Dna2, making human DNA2 one of the 226 
most efficient known motor proteins in eukaryotes. 227 
As pCtIP also modestly promotes DNA unwinding by BLM (SI Appendix, Fig. S1L)(52), we 228 
also assayed this stimulatory effect by magnetic tweezers. The DNA unwinding by BLM, as 229 
by other helicases from the RecQ family such as Sgs1, is characterized by bursts of DNA un-230 
winding followed by rewinding (Fig. 4D)(53). We observed ~1.5-fold stimulation of DNA un-231 
winding by BLM when pCtIP was included in the reaction (Fig. 4D−E). The mean BLM velocity 232 
in the absence of pCtIP was 61 ± 4 bp/s (SEM), and 91 ± 4 bp/s (SEM) in the presence of 233 
pCtIP. As with DNA2 D277A, pCtIP did not affect the processivity of BLM (SI Appendix, Fig. 234 
S4C). Additionally, pCtIP did not stimulate DNA unwinding by WRN (SI Appendix, Fig. S4D−F), 235 
in agreement with the biochemical data (SI Appendix, Fig. S1M). No DNA unwinding was ob-236 
served without ATP, or by CtIP alone (SI Appendix, Fig. S4G−K). In summary, pCtIP promotes 237 
the velocity of DNA unwinding by both BLM and DNA2 without affecting their processivity. 238 
The effect of pCtIP on DNA2 motor is much greater than that on BLM (Compare Fig. 4C and 239 
Fig. 4E). 240 
 241 
Domains of pCtIP that promote MRN and DNA2 are fully separable 242 
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The pCtIP protein is composed of an N-terminal tetramerization domain, an unstructured 243 
central region - largely lacking in S. cerevisiae - that binds DNA and contains a number of 244 
phosphorylation sites, and finally a conserved C-terminal domain that is required to activate 245 
MRN, has a secondary DNA binding site and is likewise subject to phosphorylation (Fig. 246 
5A)(10, 13, 18, 54). A key cyclin-dependent kinase site, T847, which enables cell-cycle regu-247 
lated control of DNA end resection by licensing stimulation of MRN, is located within the C-248 
terminal domain of pCtIP (Fig. 5A) (5). Only the N-terminal tetramerization and the C-termi-249 
nal domains bear limited similarity to yeast Sae2. To identify pCtIP regions that are required 250 
for the stimulation of DNA2, we designed pCtIP variants lacking stretches of amino acids 251 
from the internal region such as pCtIP D1 (lacking residues 350-600 including the DNA-bind-252 
ing region) and pCtIP D2 (lacking residues 165-790 comprising the entire region between the 253 
tetramerization domain and the Sae2-like C-terminal domain). As wild type full-length pCtIP, 254 
these internally truncated variants were expressed in Sf9 cells and purified in the presence 255 
of phosphatase inhibitors to preserve phosphorylation. We observed that pCtIP D1, but not 256 
pCtIP D2, was fully proficient in stimulating DNA2 (Fig. 5B−5C, SI Appendix, Fig. S5A). This in-257 
dicated that the region in pCtIP between residues 350 and 600 containing the DNA binding 258 
domain is dispensable for the stimulation of DNA2, and the stimulatory activity is depend-259 
ent on a region upstream or downstream of these residues. We also prepared the C-termi-260 
nal domain of pCtIP alone (pCtIP D3, containing residues 790-897), and a mutant lacking this 261 
C-terminal domain (pCtIP D4) (Fig. 5A). Remarkably, the pCtIP D4 variant, lacking the C-ter-262 
minal Sae2-like region, while incapable to stimulate MRN (SI Appendix, Fig. S5B), as ex-263 
pected (13), was fully proficient in stimulating DNA2 (Fig. 5B−5C, SI Appendix, Fig. S5A). In 264 
accord with these data, pCtIP D4, but not the pCtIP D2 variant, was capable to promote the 265 
ATPase of DNA2 (SI Appendix, Fig. S5C−F). Therefore, the regions of pCtIP that are required 266 
to promote MRN and DNA2 are distinct and physically separate.  267 
To further map the CtIP region required to stimulate DNA2, we expressed various por-268 
tions of the central CtIP domain in E. coli (Fig. 5D). We prepared the central region corre-269 
sponding to residues 350-600, as well as fragments containing additionally the upstream 270 
and downstream regions from the wider central domain (Fig. 5D). We observed that CtIP F3 271 
fragment, containing residues 350-790, was capable to promote DNA2 (Fig. 5E). This indi-272 
cated that the CtIP region downstream of residue 600 was required for DNA2 stimulation. 273 
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We note that this domain is lacking in yeast Sae2, and our result is thus in agreement with 274 
the observation that yeast Sae2 does not promote yeast or human DNA2 (Fig. 3G). We ob-275 
served that a high concentration of the F3 fragment compared to pCtIP variants expressed 276 
in insect cells was needed to observe DNA2 stimulation (compare Fig. 5C and Fig. 5E), indi-277 
cating a lower stimulatory capacity of the polypeptide expressed in E. coli compared to vari-278 
ants prepared in Sf9 cells. 279 
To narrow down the stimulatory region in pCtIP even further, we expressed in Sf9 cells 280 
and purified an additional series of internal pCtIP truncations lacking also residues down-281 
stream of position 600 (Fig. 5F, SI Appendix, Fig. S5G). We observed that pCtIP D1B fragment 282 
(lacking residues 350-690) was fully proficient in stimulating DNA2, but additional shorten-283 
ing of this mutant by 50 residues (pCtIP D1C, lacking residues 350-740) entirely eliminated 284 
this capacity (Fig. 5G−H, SI Appendix, Fig. S5H). In contrast, the pCtIP D1C construct was fully 285 
proficient in stimulating the endonuclease of MRN (Fig. 5I-5J). These experiments estab-286 
lished that the pCtIP region immediately downstream of residue 690 is required for the 287 
stimulation of the DNA2 motor activity, while it is dispensable for the stimulation of MRN.  288 
We also note that pCtIP NA/HA, which was described to lack intrinsic nuclease activity 289 
(41), and was recently found deficient in its interplay with DNA2 in response to stalled repli-290 
cation forks (55), was partially impaired in both stimulating the MRN complex (SI Appendix, 291 
Fig. S5I−S5L) as well as DNA2 (SI Appendix, Fig. S5M−S5N). Although the NA/HA mutations 292 
lie outside of the region directly involved in the stimulation of DNA2 (SI Appendix, Fig. S5J), 293 
they may affect the structure of the CtIP central domain and thus broadly impair CtIP func-294 
tions. The NA/HA mutations may thus not strictly reflect an intrinsic nuclease defect. Finally, 295 
DNA2 nuclease and helicase-dead (DNA2 D277A/K654R) had no effect on the endonuclease 296 
activity of the MRN-pCtIP complex (SI Appendix, Fig. S5O). Together, these results establish 297 
that pCtIP promotes MRN and DNA2 via distinct domains that are fully separable, and map 298 
the minimal region required for the stimulation of DNA2 between residues 690 and 790 of 299 
pCtIP. 300 
 301 
pCtIP phosphorylation facilitates its capacity to promote DNA2 302 
Due to the established requirement for pCtIP phosphorylation in the stimulation of MRN in 303 
vitro (13, 56), we set out to define the function of pCtIP phosphorylation in the regulation of 304 
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DNA2. Dephosphorylation of full-length, D1 and D4 pCtIP variants expressed in Sf9 cells dra-305 
matically reduced their capacity to stimulate DNA2 (Fig. 6A−6B, SI Appendix, Fig. S6A−S6C). 306 
Likewise, lambda phosphatase treatment of pCtIP reduced its capacity to promote DNA un-307 
winding by DNA2 D277A (SI Appendix, Fig. S6D−S6E). This is in agreement with data from 308 
Fig. 5E, where we observed limited activity of the CtIP fragment expressed in E. coli, which 309 
was expected not to be phosphorylated. 310 
Dephosphorylated CtIP and their homologs are thought to aggregate, so the apparent 311 
stimulatory function of phosphorylation may stem from abrogated CtIP aggregation (4, 57). 312 
To address whether phosphorylation enables CtIP to promote DNA2 beyond preventing ag-313 
gregation, we employed pCtIP D5, which lacks the N-terminal tetramerization domain (resi-314 
dues 1-160)(54, 58)(Fig. 6C). Lack of the tetramerization domain is expected to prevent ag-315 
gregation, even in the dephosphorylated state (4). This pCtIP variant was proficient in stimu-316 
lating DNA2, and was partially resistant to lambda phosphatase treatment (Fig. 6D−6E, SI 317 
Appendix, Fig. S6F−S6G). We then analyzed a number of point mutants non-phosphorylata-318 
ble on some of the previously-established phosphorylation sites in pCtIP, including S664A, 319 
S679A, S754A and T847A (SI Appendix, Fig. S6H). None of these mutations eliminated the 320 
capacity of pCtIP to promote DNA2 (SI Appendix, Fig. S6I), indicating that these phosphoryla-321 
tion sites are either functionally redundant, or that phosphorylation on residues other than 322 
those analyzed is important for the observed activity. 323 
We conclude that pCtIP phosphorylation clearly facilitates the stimulation of DNA2. This 324 
is likely caused, at least in part, indirectly by preventing pCtIP aggregation. Furthermore, 325 
while CtIP tetramerization is essential to stimulate MRN (13, 54), it may be dispensable to 326 
stimulate DNA2. 327 
 328 
Discussion 329 
CtIP has a well-established role as an activator of the MRE11 nuclease activity within the 330 
MRN complex, which initiates DNA end resection. This function is conserved in evolution 331 
from yeast to human cells (12, 13, 15, 59). The results presented here demonstrate that CtIP 332 
also controls DNA2, a long-range DNA end resection nuclease that functions downstream of 333 
MRE11. Therefore, similarly to SLX4 that controls a number of structure specific nucleases 334 
acting late in the recombination pathway (60, 61), CtIP controls both short-range and long-335 
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range resection nucleases (Fig. 7A). We propose that coupling of both resection steps by 336 
CtIP allows to better coordinate and regulate DNA end resection. 337 
The CtIP domains required to promote MRE11 and DNA2 are at least partially separate. 338 
We found that the very N-terminal and C-terminal domains of CtIP, while being required to 339 
promote MRE11, are largely dispensable to regulate DNA2 (Fig. 7B). Instead, we identified a 340 
region in the central domain of pCtIP between residues 690 and 790 that is essential to 341 
stimulate DNA2, but dispensable for stimulating MRN (Fig. 7B). The central domain of CtIP is 342 
lacking in homologues of low eukaryotes such as in S. cerevisiae Sae2. In accord, we failed to 343 
observe stimulation of yeast Dna2 by yeast Sae2. Therefore, while the regulation of MRE11 344 
by CtIP is conserved in evolution, the regulation of DNA2 appears to be restricted to higher 345 
eukaryotes. 346 
Deletion of SAE2 results in only limited resection defects in yeast cells. While Sae2 and 347 
the Mre11 nuclease are critical to remove Spo11, stalled topoisomerases or secondary DNA 348 
structures, the MRX-Sae2 pathway is partially dispensable for the processing of clean DSBs 349 
in yeast (62). In contrast, defects in CtIP dramatically inhibit DNA end resection in human 350 
cells, including that of nuclease-generated clean breaks (10). Accordingly, depletion of CtIP 351 
is used to abrogate resection in many experimental systems in human cells. The regulation 352 
of DNA2 by CtIP presented here thus could help explaining the differential requirement for 353 
Sae2 and CtIP in resection in high and low eukaryotes. At the same time, it is possible that 354 
the short-range resection may be generally more important in human cells. The critical func-355 
tion of CtIP could thus also result from an upstream placement of the MRN-CtIP-dependent 356 
DNA clipping. Abrogation of a critical upstream step would then mask an involvement of 357 
CtIP downstream of MRE11, explaining similar phenotypes resulting from downregulation of 358 
CtIP and chemical inhibition of the MRE11 nuclease observed in some studies (11). Other 359 
studies, including ours (SI Appendix, Fig. S1B)(49, 50), in contrast noted a more severe resec-360 
tion defects associated with CtIP depletion compared to inhibition or mutagenesis of the 361 
MRE11 nuclease active site, implicating other functions for CtIP beyond the regulation of 362 
MRE11. The differences may be due to the experimental systems used, which may have dif-363 
ferent requirements for the initial short-range resection by MRN-CtIP. Nevertheless, studies 364 
in human and murine cells, as well as Xenopus egg extracts, noted that CtIP may promote 365 
the long-range dependent pathway by DNA2 (48-50). The results presented here provide a 366 
mechanistic explanation for the CtIP and DNA2 function in this process. 367 
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Our data indicate that CtIP primarily functions to stimulate the ATPase-dependent ssDNA 368 
translocase activity of DNA2. While DNA2 is primarily active as a nuclease, the function of its 369 
helicase domain remained somewhat elusive. We previously reported that the helicase ac-370 
tivity of DNA2 becomes only apparent after inactivation of the nuclease (29, 37). Therefore, 371 
DNA2 motor does not likely function as a helicase to unwind dsDNA, but rather as a ssDNA 372 
translocase, which is readily observed with the wild type protein (38, 39). According to this 373 
model, the ssDNA translocase activity helps feed ssDNA to the nuclease domain of DNA2 374 
and facilitates thus its degradation. Moreover, DNA unwound by the cognate RecQ family 375 
helicase partner is coated by RPA, which directs the DNA2 nuclease to degrade the 5'-termi-376 
nated ssDNA strand (31, 32). However, as only naked ssDNA can pass through the channel 377 
within the DNA2 structure to reach the nuclease domain (33), RPA needs to be displaced, 378 
requiring an active mechanism. The motor activity of DNA2 plays an important function dur-379 
ing this process, as it accelerates DNA degradation primarily when RPA is present (38). The 380 
results presented here demonstrate that CtIP further accelerates the motor activity of 381 
DNA2, and thus indirectly stimulates ssDNA degradation by its nuclease domain (Fig. 7A). 382 
The stimulation of the DNA2 motor is not the only way how CtIP promotes the BLM-DNA2 383 
long-range resection pathway. Sung and colleagues previously reported that CtIP also stimu-384 
lates DNA unwinding by BLM (52), which functions upstream of DNA2 (Fig. 7A). We could 385 
confirm this stimulatory effect. In single molecule experiments, we observed that CtIP accel-386 
erated DNA unwinding by BLM by ~1.5-fold, while it stimulated DNA2 by ~10-fold under the 387 
same experimental conditions, demonstrating a comparatively larger effect of CtIP on DNA2 388 
compared to BLM.  389 
Finally, we demonstrate that phosphorylation of pCtIP facilitates its capacity to promote 390 
DNA2. Therefore, similarly to the interplay with MRE11, phosphorylation represents a key 391 
regulatory mechanism that keeps the DNA2 activity in check. Together, this allows resection 392 
only in the S-G2 phases of the cell cycle and upon DNA damage, which limits illegitimate re-393 
combination.  394 
 395 
 396 
Material and Methods 397 
 398 
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Cloning, expression and purification of recombinant proteins. Wild-type DNA2, nuclease-399 
dead DNA2 D277A, helicase-dead DNA2 K654R and double-dead DNA2 D277A K654R (DNA2 400 
DA/KR) were expressed in Spodoptera frugiperda 9 (Sf9) insect cells and purified by affinity 401 
chromatography exploiting the N-terminal 6X his-tag and the C-terminal FLAG-tag (29, 63). 402 
Yeast Dna2 was expressed in the S. cerevisiae strain WDH668 and purified using the N-ter-403 
minal FLAG tag and the C-terminal 6X his-tag (37). MRN was prepared using the 6X his and 404 
FLAG tags at the C-termini of MRE11 and RAD50, respectively (13, 63). BLM, WRN, Sae2 and 405 
wild-type CtIP,  CtIP Δ5 or CtIP T847A were obtained taking advantage of the maltose-bind-406 
ing protein (MBP) tag at the N-terminus and 10X his-tag at the C-terminus. The MBP tag was 407 
cleaved off during purification (4, 12, 13, 29). The constructs for the expression of CtIP inter-408 
nal deletion mutants (Δ1 to Δ4 and Δ1A to Δ1D) were prepared by PCR to amplify and fused 409 
the corresponding CtIP sequences and cloned into NheI and XmaI sites of pFB-2XMBP-CtIP-410 
10Xhis between the 2X MBP-tag and the 10X his-tag. CtIP N289A H290A (CtIP NA/HA) and 411 
CtIP non-phosphorylatable S664A, S679A and S745A variants were prepared by mutating 412 
the respective pFB-MBP-CtIP-his plasmid by QuickChange site-directed mutagenesis kit fol-413 
lowing manufacturer’s instructions (Agilent Technology). The truncated proteins and point 414 
mutants were expressed and purified using the same procedure as the full-length protein. 415 
For expression of phosphorylated CtIP (pCtIP) variants and phosphorylated Sae2, Sf9 cells 416 
were treated with 50 nM Okadaic acid (APExBIO) to preserve proteins in their phosphory-417 
lated state, and 1 µM camptothecin (Sigma) to further activate protein phosphorylation cas-418 
cade (13, 63). Where indicated, pCtIP was dephosphorylated with λ-phosphatase (New Eng-419 
land Biolabs) according to the manufacturer’s instructions. For ‘‘mock’’ controls, λ-phospha-420 
tase was excluded from the reactions, and the sample was otherwise incubated in the same 421 
way as the λ-phosphatase-treated reaction. The constructs coding for the CtIP fragments F1 422 
to F4 were fused with C-terminal 6X his-tag and cloned into BamHI and PstI sites in pMALT-P 423 
vector (Kowalczykowski laboratory) and expressed in E. coli BL21 DE3 pLysS cells. Purifica-424 
tion was performed by affinity chromatography using amylose (New England Biolabs) and 425 
Ni-NTA (Qiagen) resins with the same buffers and procedure described for wild-type CtIP 426 
and its variants expressed in Sf9 cells (13). Human and yeast RPA were expressed in E. coli 427 
and purified using ÄKTA pure (GE Healthcare) with HiTrap Blue HP, HiTrap desalting and 428 
HiTrap Q chromatography columns (all GE Healthcare)(63). EXO1-FLAG was expressed in Sf9 429 
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cells and purified as described in detail in supplementary information. The sequence of all 430 
primers used for PCR and cloning in this study is listed in Supplementary Table 1. 431 
 432 
Preparation of DNA substrates. Oligonucleotide-based DNA substrates were 32P-labeled ei-433 
ther at the 5ꞌ terminus with [γ-32P]ATP (Perkin Elmer) and T4 polynucleotide kinase (New 434 
England Biolabs), or at the 3 ꞌ terminus [α-32P]dCTP (Perkin Elmer) and terminal transferase 435 
(New England Biolabs) according to the manufacturer’s instructions (64). Unincorporated 436 
nucleotides were removed using Micro Bio-Spin P-30 Tris chromatography columns (Biorad). 437 
To prepare the quadruple blocked 70 bp-long dsDNA substrate, the oligonucleotides PC210 438 
and PC211 were used (Cannavo and Cejka, 2014). The sequence of all oligonucleotides used 439 
for DNA substrate preparation is listed in Supplementary Table 2. The Y-structured DNA sub-440 
strate was prepared with the oligonucleotides X12-3HJ3 and X12-3TOPL (Pinto et al., 2016). 441 
The randomly labeled 2.2-kbp-long substrate was prepared amplifying the human NBS1 442 
gene by PCR from pFB-MBP-NBS1-his plasmid (Anand et al., 2018) using Phusion high-fidel-443 
ity DNA polymerase (New England Biolabs) and the NBS1_F and NBS1_R primers. 66 nM [α-444 
32P]dCTP was added to the PCR reaction together with the standard dNTPs concentration 445 
(200 µM each). The PCR reaction product was purified using the QIAquick PCR purification 446 
kit (Qiagen) and Chroma Spin TE-200 columns (Clontech). Purified DNA was quantitated by 447 
comparing the radioactive DNA fragment with known amounts of a cold PCR product on an 448 
agarose gel stained with GelRed (Biotium). 449 
The HindIII digest of λ DNA (New England Biolabs) was labeled at the 3ꞌ end with [α-450 
32P]dATP (Perkin Elmer) and the Klenow fragment of DNA polymerase I (New England Bi-451 
olabs). Free nucleotides were removed with Micro Bio-Spin P-30 Tris chromatography col-452 
umns (Biorad). Prior to each experiment, the substrate was denatured by heating at 95°C for 453 
5 min to obtain ssDNA. For the preparation of the plasmid-length DNA substrates, the 454 
pAttP-S vector, respective annealed oligonucleotides with modified ends and ΦC31 inte-455 
grase were reacted to obtain the desired DNA fragments (64). Plasmid-length dsDNA sub-456 
strates with quadruple blocked, 5ꞌ  blocked or 3ꞌ blocked DNA ends were generated using 457 
the oligonucleotides PC210 and PC211, PC206 and PC207, PC208 and PC209, respectively 458 
(Anand et al., 2016). Subsequently, prior to experiments, each substrate was heated at 95°C 459 
for 5 min to obtain ssDNA. For the ATPase assay, the 10.3-kbp-long pFB-MBP-hMLH3 plas-460 
 16 
mid (65) was linearized with NheI restriction enzyme (New England Biolabs) and the reac-461 
tion product was purified with QIAquick PCR purification kit (Qiagen). The substrate was de-462 
natured at 95°C for 5 min before each experiment.  463 
 464 
Nuclease assays. Nuclease assays with PCR-based DNA substrates were performed in 15 µl 465 
volume in 25 mM Tris-acetate pH 7.5, 2 mM magnesium acetate, 1 mM ATP, 1 mM DTT, 0.1 466 
mg/ml BSA (New England Biolabs), 1 mM phosphoenolpyruvate (PEP), 80 U/ml pyruvate ki-467 
nase (Sigma), 50 mM NaCl and 1 nM substrate (in molecules). Human RPA was included as 468 
indicated to saturate all ssDNA. Additional recombinant proteins were then added on ice 469 
and the reactions were incubated at 37°C as indicated to perform kinetic experiments. Reac-470 
tions were stopped by adding 5 µl of 2% stop solution (150 mM EDTA, 2% sodium dodecyl 471 
sulfate, 30% glycerol, bromophenol blue) and 1 µl of proteinase K (Sigma) and incubated at 472 
37°C for 10 min. Samples were analyzed by 1% agarose gel electrophoresis. Gels were dried 473 
on DE81 chromatography paper (Whatman), exposed to storage phosphor screens (GE 474 
Healthcare) and scanned by a Typhoon 9500 phosphorimager (GE Healthcare). Analysis of 475 
ssDNA degradation was performed with 0.15 nM (in molecules) 3'-labeled λ DNA/HindIII 476 
fragments that were heat-denatured for 5 min at 95°C before adding to the reaction mix-477 
ture. Differently from above, the reaction buffer contained 3 mM magnesium acetate, no 478 
salt, and, unless indicated otherwise, reactions were incubated at 37°C for 8 min. When 479 
yeast proteins were used, the experiment was performed at 25°C for 1 min and yeast RPA 480 
was added in each reaction.  Nuclease assays with 32P-labeled Y-shaped DNA substrate (0.1 481 
nM in molecules) were carried out in a similar buffer containing 100 mM NaCl at 37°C and 482 
the reactions were stopped by adding 0.5 µl ethylenediaminetetraacetic (0.5 M EDTA) and 1 483 
μl Proteinase K, and incubated at 50°C for 30 min. An equal amount of formamide dye (95% 484 
[v/v] formamide, 20 mM EDTA, bromophenol blue) was added and samples were heated at 485 
95°C for 4 min and separated on 15% denaturing polyacrylamide gels (ratio acryla-486 
mide:bisacrylamide 19:1, Biorad). After fixing in a solution containing 40% methanol, 10% 487 
acetic acid and 5% glycerol for 30 min the gels were dried on 3 mm paper (Whatman) and 488 
analyzed as described above. Endonuclease assays with MRN and phosphorylated CtIP (15 489 
µl volume) were performed in nuclease buffer containing 25 mM Tris-HCl pH 7.5, 5 mM 490 
magnesium acetate, 1 mM manganese acetate, 1 mM ATP, 1 mM DTT, 0.25 mg/ml BSA, 1 491 
mM phosphoenolpyruvate, 80 U/ml pyruvate kinase, and 1 nM oligonucleotide-based DNA 492 
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substrate (in molecules). Biotinylated DNA ends were blocked by adding 15 nM streptavidin 493 
and incubating the samples 5 min at room temperature. Samples were then processed and 494 
analyzed as described above with 15% denaturing gels (13, 64). Where unlabeled pAttP-S 495 
based DNA substrates were used, the reaction buffer was prepared with no salt, but with 3 496 
mM magnesium acetate and 30 nM streptavidin to block biotinylated DNA ends as indi-497 
cated. Reactions were incubated at 37°C for 30 min and DNA was visualized by staining with 498 
GelRed (Biotium).  499 
 500 
Helicase assays. Helicase assays (15 µl volume) were performed in a reaction buffer (25 mM 501 
Tris-acetate pH 7.5, 5 mM magnesium acetate, 1 mM ATP, 1 mM DTT, 0.1 mg/ml BSA, 1 mM 502 
PEP, 80 U/ml pyruvate kinase and 50 mM NaCl) with 0.1 nM of oligonucleotide-based DNA 503 
substrate (in molecules). Recombinant proteins were added as indicated. Unless specified 504 
otherwise, reactions were incubated at 37°C for 30 min and stopped as described for nucle-505 
ase assay with PCR-based DNA substrate. To avoid re-annealing of the substrate, the 2% 506 
stop solution was supplemented with a 20-fold excess of the unlabeled oligonucleotide with 507 
the same sequence as the 32P labeled one. The products were separated by 10% polyacryla-508 
mide gel electrophoresis, dried on 17 CHR chromatography paper (Whatman) and analyzed 509 
as defined for nuclease assays.  510 
 511 
ATPase assays. The ATPase assays were performed in 25 mM Tris-acetate (pH 7.5), 3 mM 512 
magnesium acetate, 1 mM DTT, 0.1 mg/ml BSA, 1 mM ATP, 1 nM of [γ-32P] adenosine 5ꞌ-tri-513 
phosphate (Perkin Elmer) and 0.32 nM (in molecules) of the heat-denatured plasmid-based 514 
DNA substrate. RPA and recombinant proteins were added on ice and samples were incu-515 
bated at 37°C for 10 min. Reactions were stopped with 1.1 µl of 0.5 M EDTA and separated 516 
using TLC plates (Merk) and 0.3 M LiCl and 0.3 M formic acid as mobile phase. Dried plates 517 
were exposed to storage phosphor screens (GE Healthcare) and scanned by a Typhoon 9500 518 
phosphorimager (GE Healthcare). 519 
 520 
Protein interaction assays. To test for interactions between DNA2 and phosphorylated CtIP, 521 
his-DNA2-FLAG was expressed in Sf9 cells, cells were lysed and soluble extract containing 522 
his-DNA2-FLAG was bound to M2 anti FLAG affinity resin (50 µl, Sigma). The resin was 523 
washed with wash buffer 1 (50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% glycerol, 1 mM 524 
 18 
PMSF, 0.5 mM β-mercaptoethanol, 0.1% NP40) and incubated for 1 h at 4°C with recombi-525 
nant purified pCtIP (1 µg) in IP buffer (25 mM Tris-HCl pH 7.5, 0.5 mM DTT, 3 mM EDTA, 100 526 
mM NaCl, 0.20 µg/µl BSA). The resin with bound proteins was  washed 5 times with wash 527 
buffer 2 (50 mM Tris-HCl pH 7.5, 0.5 mM DTT, 3 mM EDTA, 80 mM NaCl, 0.1% NP40), and 528 
proteins were eluted with wash buffer 2 (70 µl) containing 150 ng/µl of FLAG peptide 529 
(APExBIO). As a negative control, purified pCtIP was incubated with the resin that had not 530 
been bound to his-DNA2-FLAG. The proteins in the eluate were analyzed by western blot-531 
ting using anti-FLAG primary antibody (Sigma, F3165 diluted 1:1000 in 5% milk in TBS-T) 532 
against DNA2-FLAG or anti-CtIP primary antibody (Active Motif, 61141 diluted 1:1000 in 533 
blocking solution) using standard procedures.  534 
 535 
Magnetic tweezers assay. The DNA construct for single-molecule experiments containing a 536 
40 nt flap at an adjacent 38 nt gap (see Fig. 4A) was prepared as described before (29, 37, 53). 537 
To produce the main 6.6 kbp fragment, pNLrep plasmid (66) was digested with BamHI and 538 
BsrGI restriction enzymes. Simultaneously, a 63 nt gap was created by codigesting five 15 nt 539 
spaced BbvCI sites using the nicking enzyme Nt.BbvCI. Into the gap a 65 nt long oligonucleo-540 
tide possessing a 25 nt complementary sequence and a 40 nt long polithymidine tail was hy-541 
bridized. In a subsequent ligation step the oligomer was ligated at its 3ꞌ end inside the gap. 542 
Also 600 bp long digoxigenin- and biotin-modified handles were ligated with corresponding 543 
sticky ends to the termini of the 6.6 kbp fragment. 544 
Single-molecule experiments were carried out in a custom-made magnetic tweezers setup 545 
(67, 68). The DNA constructs were attached at their biotinylated end to 2.8 µm streptavidin-546 
coated magnetic beads (Dynabeads M280, Thermo Fischer Scientific) and flushed into the 547 
fluidic cell, whose bottom slide was covered with antidigoxigenin. After a short incubation 548 
to allow the attachment of the digoxigenin-modified DNA end, the excess of the magnetic 549 
beads was washed away. Lowering the magnets of the setup allowed to stretch DNA mole-550 
cules tethered to the magnetic beads. Tracking of the magnetic bead position was per-551 
formed at 300 Hz using video microscopy and real-time GPU-accelerated image analysis 552 
(68). Magnetic forces were calibrated using fluctuation analysis (69). The DNA unwinding ex-553 
periments were performed at 37 °C in reaction buffer containing 25 mM Tris-acetate pH 7.5, 554 
5 mM magnesium acetate, 1 mM ATP, 1 mM DTT and 0.1 mg/ml BSA. 2 mM magnesium ac-555 
etate was used when WRN was present in the reactions. DNA unwinding was initiated by 556 
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adding equimolar mixtures of 25 nM RPA, 25 nM DNA2 D277A, 25 nM pCtIP and/or 25 nM 557 
BLM or WRN (as indicated in the text) in reaction buffer into the fluidic cell. For temperature 558 
control of the setup an objective heater (Okolab, Pozzuoli, Italy) was employed. Analysis of 559 
unwinding velocities and processivities was carried out using a custom-written MATLAB pro-560 
gram (70). Errors of obtained rates and processivities are given as standard error of the 561 
mean (SEM) throughout. 562 
 563 
SSA reporter assay. 0.4 × 105 SA-GFP U2OS cells were seeded in 0.5 ml antibiotic-free media 564 
onto 24-well plates with 5 pmol siRNA (siCTRL, 5ꞌ -TGGTTTACATGTCGACTAA; siCtIP, 5ꞌ -565 
GCTAAAACAGGAACGAATC) and 1.8 µl RNAiMAX (Invitrogen) in 100 µl Opti-MEM (Gibco) 566 
and cultured for 20 h. The cells were transfected with 0.4 µg I-SceI (pCBASce) and 0.2 µg 567 
empty vector (pcDNA3.1) with Lipofectamine 2000 (Invitrogen) in 100 µl Opti-MEM and 0.5 568 
ml antibiotic-free media for 3 hr. After the I-SceI transfection, cells were washed and 569 
treated with MRE11 inhibitors 50 µM PFM03 and 50 µM PFM39 (from Davide Moiani and 570 
John Tainer, MD Anderson Cancer Center)(11) or mock-treated with DMSO and cultured for 571 
3 days to allow for the repair of the DSB. Cells were then scored for percentage of GFP-posi-572 
tive cells on a LSR Fortessa flow cytometer (BD). 573 
 574 
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Supplemental experimental procedures 755 
 756 
Cloning, expression and purification of recombinant proteins 757 
 758 
The human EXO1 gene was amplified by PCR using HEXO1FO and HEXO1RE primers to intro-759 
duce BamHI and XmaI restriction sites as well as C-terminal FLAG tag. The PCR product was 760 
digested with BamHI and XmaI restriction endonucleases (New England Biolabs) and ligated 761 
into pFastBac1 (Invitrogen), generating pFB-EXO1-FLAG. Human EXO1 was expressed in Sf9 762 
insect cells in SFX Insect serum-free medium (Hyclone) using the Bac-to-Bac expression sys-763 
tem (Invitrogen), according to manufacturer’s recommendations. Frozen Sf9 pellet from 800 764 
ml culture was resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 0.5 mM β-mercaptoetha-765 
nol, 1 mM EDTA, 1:400 protease inhibitor cocktail [Sigma], 20 µg/ml leupeptine [Merck Mil-766 
lipore], 0.5 mM PMSF) and incubated at 4°C for 10 min. Glycerol was added to a final con-767 
centration of 25%, NaCl was added to a final concentration of 305 mM and the solution was 768 
incubated at 4°C for 30 min. The mixture was centrifuged at 55000 g at 4°C for 30 min. The 769 
soluble extract was incubated with M2 anti FLAG affinity resin (Sigma) at 4°C for 30 minutes. 770 
FLAG resin was washed with TBS wash buffer (20 mM Tris-HCl pH 7.5, 0.5 mM β-mercap-771 
toethanol, 0.5 mM PMSF, 1 mM EDTA, 1:1000 protease inhibitor cocktail, 6.7 µg/ml leupep-772 
tine, 10% glycerol, 150 mM NaCl) supplemented with 0.1 % NP40. The last wash was per-773 
formed with the same buffer but without NP40.  Protein was eluted using TBS wash buffer 774 
without NP40 supplemented with 200 µg/ml 3XFLAG peptide (Sigma). Peak fractions, as es-775 
timated by the Bradford method, were pooled and diluted by adding 1.5 volumes of dilution 776 
buffer (50 mM Tris-HCl pH 7.5, 5 mM β-mercaptoethanol, 0.5 mM PMSF, 6.7 µg/ml leupep-777 
tine, 10% glycerol). The diluted fractions were loaded on HiTrap SP HP cation exchange 778 
chromatography column (GE Healthcare) (0.8 ml/min) and washed with buffer A (50 mM 779 
Tris-HCl pH 7.5, 5 mM β-mercaptoethanol, 10% glycerol, 75 mM NaCl). Proteins were eluted 780 
using a 5 ml gradient of 75 mM to 1 M NaCl in 0.8 ml fractions. Peak fractions were pooled, 781 
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Table S1. List of oligonucleotides used for cloning and site-directed mutagenesis in this 787 
study. 788 
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NBS1_R GATTTGCG CTCGAG TTA CCCGGG TCTTCTCCTTTTTAAATAAG  
 Table S2. List of oligonucleotides used for oligonucleotide-based DNA substrate in this 790 
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Figure 1 − pCtIP promotes DNA2-dependent long-range DNA end resection pathway
A. DNA end resection by WRN, DNA2 and human RPA (176 nM) using 2.2 kbp-long randomly labelled dsDNA substrate in 
the presence or absence of phosphorylated CtIP (pCtIP).  The reaction buffer contained 50 mM NaCl. Reaction products 
were separated by 1% agarose gel electrophoresis. Panel shows a representative experiment. Red asterisks indicate random 
labelling. 
B. Representative 15% denaturing polyacrylamide gel showing the degradation kinetics of a Y-structured (45nt/48 bp) DNA 
by DNA2 with or without pCtIP, in the presence of human RPA (15 nM) and 100 mM NaCl. Red asterisk indicates the 
position of the labelling. 
C. Quantitation of overall substrate utilization from experiments such as shown in panel B. N=3; error bars, SEM.
D. A representative experiment showing DNA unwinding by nuclease-deficient DNA2 D277A with or without pCtIP on 
oligonucleotide-based Y-structured (45 nt/48 bp) DNA. Reactions were supplemented with human RPA (7.5 nM) and 50 mM 
NaCl and analysed on 10% native acrylamide gel electrophoresis. Red asterisk indicates the position of the labelling. 
E. Quantitation of overall substrate unwinding from experiments such as shown in panel D. N=3; error bars, SEM.
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Figure 2 − pCtIP dramatically promotes degradation of long stretches of ssDNA by DNA2
A. Representative 1% agarose gel showing degradation kinetics of 3' 32P-labeled ssDNA fragments (derived from λDNA) of 
various lengths by DNA2 without or with pCtIP in the presence of 864 nM human RPA. The sizes of the corresponding dsDNA 
fragments are indicated on the left. Red asterisk indicates the position of the labelling. 
B. Quantitation of products smaller than ~300 nt from experiments such as shown in panel A. N=3; error bars, SEM.
C. Representative experiment as in A with various concentration of pCtIP incubated for 8 min.
D. Quantitation of data such as shown in panel C; N=3; error bars, SEM. The degradation activity of pCtIP alone is the same as 
in Fig. 3A (lane 7). 
E. Experiment such as in A with various concentration of DNA2 incubated for 8 min in the presence or absence of pCtIP.
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Figure 3 − The motor activity of DNA2 mediates the accelerated ssDNA degradation with pCtIP
A. Degradation of ssDNA fragments (derived from λDNA) of various lengths by DNA2 in the presence or absence of pCtIP 
without or with ATP, as indicated. All reactions contained human RPA (864 nM). The experiment was incubated at 37°C for 8 
min. ATP is required for the stimulatory effect of pCtIP on DNA2. Red asterisk indicates the position of the labelling. 
B. Quantitation of data such as shown in panel A. N=3; error bars, SEM.
C. Degradation of ssDNA fragments by wild type, helicase-deficient K654R or nuclease-deficient D277A DNA2 variants without 
or with pCtIP. All reactions contained human RPA (864 nM). The experiment was incubated at 37°C for 8 min.
D. Quantitation of small degradation products from experiment such as shown in panel C. N=3; error bars, SEM.
E. ATP hydrolysis by DNA2 alone (10 nM) or with pCtIP (40 nM). Reactions contained 10.3 kbp-long substrate denatured at 
95°C for 5 min, 395.5 nM human RPA and no added salt.
F. Quantitation of ATP hydrolysis from experiments such as shown in panel E. N=3; error bars, SEM.
G. Degradation of ssDNA fragments by human or yeast DNA2/Dna2 without or with human pCtIP or yeast pSae2. Reactions 
with human DNA2 were carried out at 37°C for 8 min with human RPA (864 nM). Reactions with yeast Dna2 were performed 
at 25°C for 1 min with yeast RPA (1.09 µM).
H. Analysis of DNA2 interaction with pCtIP. DNA2-FLAG was immobilized on M2 anti-FLAG affinity resin and incubated with 





Figure 4 − Single-molecule experiments demonstrate accelerated DNA2 motor activity in the presence of pCtIP.
A. Sketch of the employed magnetic tweezers assay and the DNA construct carrying a 40 nt 5' flap to allow loading of either 
helicase. 
B. Representative DNA unwinding events of the DNA2 nuclease-dead mutant (D277A, 25 nM) in the absence (orange) and 
presence (green) of pCtIP (25 nM).  Both reactions were also supplemented with 25 nM human RPA.
C. Histograms of the observed unwinding velocities for nuclease-dead DNA2 (N = 40 traces for each case). 
D. Representative DNA unwinding events of BLM (25 nM) in the absence (magenta) and presence (purple) of pCtIP (25 nM).
E. Histogram of the observed unwinding velocities for BLM. (N = 852 events). The force in all experiments was F = 19 ± 3 pN
(SD).
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Figure 5 − Separate domains of pCtIP promote the MRN and DNA2 nucleases
A. A schematic representation of the primary structure of wild type pCtIP and internal deletion variants (pCtIP D1-4) purified 
from Sf9 cells in the presence of phosphatase inhibitors. Main ATM phosphorylation sites are indicated in red, CDK 
phosphorylation sites are indicated in blue. 
B. Degradation ssDNA fragments of various lengths by DNA2 without or with pCtIP variants, as indicated. All reactions 
contained human RPA (864 nM). Red asterisk indicates the position of the labelling. 
C. Quantitation of data such as shown in panel B. N=3-4; error bars, SEM.
D. A schematic representation of purified recombinant CtIP fragments (F1-F3) expressed in E. coli. pCtIP wild type purified 
from Sf9 cells is again shown as a reference.
E. Quantitation of ssDNA fragment degradation into products smaller than ~300 nt by DNA2 without or with F1-F3 CtIP 
fragments. N=3; error bars, SEM.
F. A schematic representation of internal deletion variants (pCtIP D1A-Δ1D) purified from Sf9 cells in the presence of 
phosphatase inhibitors. pCtIP wild type is again shown as a reference.
G. Degradation of ssDNA fragments of various lengths by DNA2 without or with various concentrations of wild type pCtIP or 
Δ1A- Δ1D mutants, in the presence of human RPA (864 nM).
H. Quantitation of data such as shown in panel G. N=3; error bars, SEM.
I. Endonuclease assay with MRN (25 nM) and wild type full-length or pCtIP Δ1B and Δ1C variants. Red asterisk indicates the 
position of the labelling. 
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Figure 6 − pCtIP phosphorylation facilitates its capacity to promote DNA2
A. Degradation of ssDNA fragments of various length with DNA2 alone (20 nM) or with pCtIP wild type, Δ1, Δ2, Δ3, Δ4, mock-
treated or λ-treated, in the presence of human RPA (864 nM). Red asterisk indicates the position of the labelling. 
B. Quantitation of small degradation products from experiments such as shown in panel A. N=4; error bars, SEM.
C. A schematic representation of purified recombinant pCtIP Δ5 lacking the first 160 amino acids. pCtIP wild type is again 
shown as a reference.
D. Degradation of ssDNA fragments of various length with DNA2 alone (20 nM) or with pCtIP wild type or Δ5, mock-treated or 
λ-treated, in the presence of human RPA (864 nM). 




Figure 7 − Model for pCtIP functions in DNA end resection 
A. A cartoon depicting the role of pCtIP in short-range resection by MRE11 within the MRN complex and in long-range 
resection by DNA2-BLM. In long-range resection, pCtIP stimulates both the translocase activity of DNA2 to facilitate 
degradation of RPA-coated ssDNA, and the helicase activity of BLM to unwind dsDNA.
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Supplementary Figure 1 (related to Figure 1)
A. Nuclease assay with MRN and various concentrations of phosphorylated CtIP (pCtIP) on a 5’ end-labeled 70 bp-long dsDNA 
blocked at both ends with streptavidin. Red asterisk indicates the position of the labelling. 
B. Single-strand annealing reporter assay. CtIP was depleted by siRNA, where indicated, or non-targeting siRNA was used as a 
negative control (siCTRL). Where indicated, the cells were treated with 50 µM PFM03 and 50 µM PFM39 MRE11 nuclease 
inhibitors (MRE11i). N = 4; error bars, SD. 
C-G. Purified proteins used in this study. The polyacrylamide gels were stained with Coomassie Brilliant Blue. * indicates 
degradation products.
H. 2.2 kbp-long dsDNA degradation by EXO1 with or without pCtIP. Panel shows a representative experiment carried out with 
human RPA (176 nM) and 50 mM NaCl. Red asterisks indicate random labelling. 
I. DNA end resection by BLM, DNA2 and human RPA (176 nM) in the absence or presence of pCtIP. Panel shows a 
representative experiment performed with 50 mM NaCl. Red asterisks indicate random labelling. 
J. Quantitation of overall substrate utilization from experiments such as shown in panel I. N=3; error bars, SEM.
K. Quantitation of small degradation products from experiments such as shown in panel I. N=3; error bars, SEM.
L. Unwinding of Y-structured DNA by BLM with or without pCtIP, in the presence of human RPA (7.5 nM) and 50 mM NaCl. 
Moderate DNA stimulation of DNA unwinding by pCtIP was observed. Red asterisk indicates the position of the labelling. 
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Supplementary Figure 2 (related to Figure 2)
A. 2.7 knt long ssDNA substrates blocked with streptavidin at both ends (lanes 1-5), at the 5' end (lane 6-10) or at the 3' end 
(lanes 11-15), were reacted at 37°C for 30 minutes with DNA2 and/or CtIP in the presence of human RPA (829.8 nM). The gel 
was stained with GelRed. 
B. Quantitation of overall remaining substrate from experiments such as shown in panel A. N=3; error bars, SEM. DNA2 
preferentially degrades the ssDNA substrate from the 5' end.
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BA C
Supplementary Figure 3 (related to Figure 3)
A. ATP hydrolysis by wild type or helicase-deficient K654R DNA2 alone or in the presence of pCtIP. Reactions contained 10.3 
kbp-long dsDNA substrate denatured at 95°C for 5 min, and 395.5 nM human RPA.
B. Quantitation of small degradation products generated by human DNA2 with pCtIP or pSae2 from experiments such as 
shown in Fig. 3G. N=3; error bars, SEM.
C. Quantitation of small degradation products generated by yeast Dna2 with pSae2 or pCtIP from experiments such as shown 
in Fig. 3G. N=3; error bars, SEM. 
Supplementary Figure 4 (related to Figure 4)
BA C
HG I J
Supplementary Figure 4 (related to Figure 4)
A. Representative DNA unwinding events of nuclease-dead DNA2 (D277A) in the absence of pCtIP as presented in Fig. 4 shown 
over the full experimental timescale. 
B. Cumulative probability distributions (shown as survival probability) of the processivity of the individual unwinding events of 
nuclease dead DNA2 D277A in the absence (orange) and presence (green) of pCtIP with mean values of 3.7±0.3 kbp (SEM) and 
3.5±0.3 kbp (SEM), respectively. 
C. Cumulative probability distributions of the processivity of the individual unwinding events of BLM in the absence (magenta) 
and presence (purple) of pCtIP with mean values of 179±13 bp (SEM) and 197±15 bp (SEM), respectively. 
D. Representative DNA unwinding events of WRN in the absence (red) and presence (blue) of pCtIP.
E. Histograms of the observed unwinding velocities for WRN in the absence (red) and presence (blue) of CtIP with mean values 
of 28 ± 2 bp/s (SEM) (N = 751) and 28 ± 3 bp/s (SEM) (N = 547), respectively.
F. Cumulative probability distributions of the processivity of the individual unwinding events of WRN in the absence (red) and 
presence (blue) of pCtIP with mean values of 126 ± 10 bp (SEM) and 134 ± 11 bp (SEM), respectively. 
G−K. DNA unwinding studied by: (G) DNA2 D277A and human RPA in the absence of ATP, (H) human RPA and ATP in the 
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Supplementary Figure 5 (related to Figure 5)
A. Experiment as in Fig. 5B, but carried out only with wild type phosphorylated CtIP or internal deletion variants, in the 
presence of human RPA (864 nM).
B. Endonuclease assay with MRN (25 nM) and wild type full-length or pCtIP Δ4 variants. Red asterisk indicates the position of 
the labelling. 
C. ATP hydrolysis by DNA2 without or with pCtIP and its variants. Reactions contained 10.3 knt-long ssDNA, 395.5 nM human 
RPA and no added salt. The ATPase activity of DNA2 alone or with wild type pCtIP is the same as shown in Fig. 3E and is shown
again as a reference.
D. Quantitation of data such as shown in panel C. N=3; error bars, SEM. The ATPase activity of DNA2 alone and with wild type 
pCtIP is the same as in Fig. 3E.
E. ATP hydrolysis by nuclease-deficient DNA2 D277A without or with pCtIP variants, as indicated. Reactions contained 10.3 
knt-long ssDNA, 395.5 nM human RPA and no salt.
F. Quantitation of data such as shown in panel E. N=3; error bars, SEM.
G. Gradient (4-15%) polyacrylamide gels (Biorad) stained with Coomassie blue showing fractions from representative 
purifications of pCtIP Δ1A− Δ1D variants. SE, soluble extract; FT, flow through; EL, eluate.
H. Experiment as in Fig. 5G, but carried out only with wild type phosphorylated CtIP or internal deletion variants, in the 
presence of human RPA (864 nM).
I. Recombinant pCtIP NA/HA mutant analyzed on a polyacrylamide gel stained with Coomassie Brilliant Blue.
J. A schematic representation of the positions of the mutations in the pCtIP NA/HA variant. pCtIP wild-type is again shown as a 
reference.
K. Endonuclease assay with MRN (25 nM) and various concentrations of wild type pCtIP or the NA/HA mutant. Red asterisk 
indicates the position of the labelling. 
L. Quantitation of data such as shown in panel J. N=3; error bars, SEM.
M. Degradation of ssDNA fragments of various lengths by DNA2 without or with various concentrations of wild type pCtIP or 
the NA/HA mutant, in the presence of human RPA (864 nM). Red asterisk indicates the position of the labelling. 
N. Quantitation of data such as shown in panel L. N=3, error bars, SEM.
O. Endonuclease assay with MRN (25 nM) and various concentrations of pCtIP, with or without nuclease-helicase-deficient 
DNA2 D277A K654R. Red asterisk indicates the position of the labelling. 
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Supplementary Figure 6 (related to Figure 6)
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Supplementary Figure 6 (related to Figure 6)
A. Electrophoretic mobility of pCtIP either not-treated (lane 2) or treated (lane 3) with λ phosphatase. The pCtIP variants were
separated on a gradient (4-15%) polyacrylamide gel (Biorad) and stained with Coomassie Brilliant Blue.
B. Electrophoretic mobility of pCtIP variants Δ1, Δ2, Δ3 or Δ4 either not-treated or treated with λ phosphatase. The CtIP 
variants were separated on a gradient (4-15%) polyacrylamide gel (Biorad) and stained with Coomassie Brilliant Blue.
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Supplementary Figure 6 (related to Figure 6) continued
D. A representative experiment showing the unwinding activity of nuclease-deficient DNA2 D277A without or with mock-
treated or λ-treated pCtIP on an oligonucleotide-based Y-structured (45 nt/48 bp) DNA substrate. Reactions were 
supplemented with human RPA (7.5 nM) and 50 mM NaCl, and analyzed by electrophoresis in a native 10% polyacrylamide 
gel. Red asterisk indicates the position of the labelling. 
E. Quantitation of data such as shown in panel D. N=3, error bars, SEM.
F. Electrophoretic mobility of pCtIP variant Δ5 either treated (lane 2) or not-treated (lane 3) with λ phosphatase.
G. Experiment as in Fig. 6D, but carried out without DNA2.
H. A schematic representation of purified recombinant non-phosphorylatable pCtIP variants (S664A, S679A, S745A, T847A). 
pCtIP wild type is again shown as a reference.
I. Degradation of ssDNA fragments of various length with DNA2 alone (20 nM) or with pCtIP wild type or non-
phosphorylatable variants, in the presence of human RPA (864 nM). Red asterisk indicates the position of the labelling. 
